|
1
|
Kamada Y, Suzukawa K, Taoka K, Okoshi Y,
Hasegawa Y and Chiba S: Relapse of acute myeloid leukemia with t
(16; 21)(p11; q22) mimicking autoimmune pancreatitis after second
allogeneic bone marrow transplantation. ISRN Hematol.
2011:2854872011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vieira L, Oliveira V, Ambrósio AP, Marques
B, Pereira AM, Hagemeijer A and Boavida MG: Translocation
(8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2). a
four-way variant of t(8;21). Cancer Genet Cytogenet. 128:104–107.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wong KF, Kwong YL and So CC: De novo AML
with trilineage myelodysplasia and a novel t(11;12)(p15;q13).
Cancer Genet Cytogenet. 100:49–51. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taketani T, Taki T, Shibuya N, Kikuchi A,
Hanada R and Hayashi Y: Novel NUP98-HOXC11 fusion gene resulted
from a chromosomal break within exon 1 of HOXC11 in acute myeloid
leukemia with t(11;12)(p15;q13). Cancer Res. 62:4571–4574.
2002.PubMed/NCBI
|
|
5
|
LaStarza R, Trubia M, Crescenzi B,
Matteucci C, Negrini M, Martelli MF, Pelicci PG and Mecucci C:
Human homeobox gene HOXC13 is the partner of NUP98 in adult acute
myeloid leukemia with t(11;12)(p15;q13). Genes Chromosomes Cancer.
36:420–423. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Panagopoulos I, Isaksson M, Billström R,
Strömbeck B, Mitelman F and Johansson B: Fusion of the NUP98 gene
and the homeobox gene HOXC13 in acute myeloid leukemia with
t(11;12)(p15;q13). Genes Chromosomes Cancer. 36:107–112. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gu BW, Wang Q, Wang JM, Xue YQ, Fang J,
Wong KF, Chen B, Shi ZZ, Shi JY, Bai XT, et al: Major form of
NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13)
translocation exhibits aberrant trans-regulatory activity.
Leukemia. 17:1858–1864. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tosić N, Stojiljković M, Colović N,
Colović M and Pavlović S: Acute myeloid leukemia with NUP98-HOXC13
fusion and FLT3 internal tandem duplication mutation: Case report
and literature review. Cancer Genet Cytogenet. 193:98–103. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
LaStarza R, Brandimarte L, Pierini V,
Nofrini V, Gorello P, Crescenzi B, Berchicci L, Matteucci C, Romoli
S, Beacci D, et al: A NUP98-positive acute myeloid leukemia with a
t(11;12)(p15;q13) without HOXC cluster gene involvement. Cancer
Genet Cytogenet. 193:109–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Such E, Cervera J, Valencia A, Barragán E,
Ibañez M, Luna I, Fuster O, PerezSirvent ML, Senent L, Sempere A,
et al: A novel NUP98/RARG gene fusion in acute myeloid leukemia
resembling acute promyelocytic leukemia. Blood. 117:242–245. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gong BF, Li QH, Li W, Wang Y, Wei H, Wang
JY, Zhao XL, Lin D, Li CW, Liu XP, et al: Acute myeloid leukemia
with t(11;12)(p15;q13) translocation: Two cases report and
literature review. Zhonghua Xue Ye Xue Za Zhi. 34:830–833. 2013.(In
Chinese). PubMed/NCBI
|
|
12
|
Masuya M, Katayama N, Inagaki K, Miwa H,
Hoshino N, Miyashita H, Suzuki H, Araki H, Mitani H, Nishii K, et
al: Two independent clones in myelodysplastic syndrome following
treatment of acute myeloid leukemia. Int J Hematol. 75:182–186.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Taketani T, Taki T, Nakamura T, Kobayashi
Y, Ito E, Fukuda S, Yamaguchi S and Hayashi Y: High frequencies of
simultaneous FLT3-ITD, WT1 and KIT mutations in hematological
malignancies with NUP98-fusion genes. Leukemia. 24:1975–1977. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pratz KW, Sato T, Murphy KM, Stine A,
Rajkhowa T and Levis M: FLT3-mutant allelic burden and clinical
status are predictive of response to FLT3 inhibitors in AML. Blood.
115:1425–1432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gale RE, Green C, Allen C, Mead AJ,
Burnett AK, Hills RK and Linch DC: Medical Research Council Adult
Leukaemia Working Party: The impact of FLT3 internal tandem
duplication mutant level, number, size, and interaction with NPM1
mutations in a large cohort of young adult patients with acute
myeloid leukemia. Blood. 111:2776–2784. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Whitman SP, Ruppert AS, Radmacher MD,
Mrózek K, Paschka P, Langer C, Baldus CD, Wen J, Racke F, Powell
BL, et al: FLT3 D835/I836 mutations are associated with poor
disease-free survival and a distinct gene-expression signature
among younger adults with de novo cytogenetically normal acute
myeloid leukemia lacking FLT3 internal tandem duplications. Blood.
111:1552–1559. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martelli MP, Pettirossi V, Thiede C,
Bonifacio E, Mezzasoma F, Cecchini D, Pacini R, Tabarrini A,
Ciurnelli R, Gionfriddo I, et al: CD34+ cells from AML with mutated
NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia
in immunocompromised mice. Blood. 116:3907–3922. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schnittger S, Kern W, Tschulik C, Weiss T,
Dicker F, Falini B, Haferlach C and Haferlach T: Minimal residual
disease levels assessed by NPM1 mutation-specific RQ-PCR provide
important prognostic information in AML. Blood. 114:2220–2231.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Xu WL, Meng HT, Qian WB, Mai WY,
Tong HY, Mao LP, Tong Y, Qian JJ, Lou YJ, et al: FLT3 and NPM1
mutations in Chinese patients with acute myeloid leukemia and
normal cytogenetics. J Zhejiang Univ Sci B. 11:762–770. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Falini B, Martelli MP, Bolli N,
Sportoletti P, Liso A, Tiacci E and Haferlach T: Acute myeloid
leukemia with mutated nucleophosmin (NPM1): is it a distinct
entity? Blood. 117:1109–1120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Haferlach T, Bacher U, Alpermann T,
Haferlach C, Kern W and Schnittger S: Amount of bone marrow blasts
is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML
with normal karyotype. Leuk Res. 36:51–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dunlap J, Beadling C, Warrick A, Neff T,
Fleming WH, Loriaux M, Heinrich MC, Kovacsovics T, Kelemen K,
Leeborg N, et al: Multiplex high-throughput gene mutation analysis
in acute myeloid leukemia. Hum Pathol. 43:2167–2176. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dang H, Jiang A, KamelReid S, Brandwein J
and Chang H: Prognostic value of immunophenotyping and gene
mutations in elderly patients with acute myeloid leukemia with
normal karyotype. Hum Pathol. 44:55–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishiyama M, Arai Y, Tsunematsu Y,
Kobayashi H, Asami K, Yabe M, Kato S, Oda M, Eguchi H, Ohki M, et
al: 11p15 translocations involving the NUP98 gene in childhood
therapy-related acute myeloid leukemia/myelodysplastic syndrome.
Genes Chromosomes Cancer. 26:215–220. 1999. View Article : Google Scholar : PubMed/NCBI
|
